Request a Meeting Conference Website

Join us at ICPE 2023 where our experts in epidemiology, safety, and real-world data will participate in scientific sessions, present on new and innovative research and be available to discuss how we can support your real-world evidence needs.

View a list of our presentations below, and stop by #306 to learn how our real-world evidence and data solutions and experts in post-marketing safety studies can help you advance your drug development towards approval and market access.

Pre-Conference Course

Thursday, August 24

2:00 p.m. – 6:00 p.m. ADT

Science-Based Approaches and Case Studies for Designing and Evaluation Effective Interventions for the Safe Use of Medicinal Products

Evidera Presenter: Meredith Y. Smith, PhD, MPA, FISPE

Symposia Presentations

Friday, August 25

10:30 a.m. – 12:00 p.m. ADT

Developing Code Lists for Pharmacoepidemiology: The How and Why

PPD Presenter: Susan Oliveria, ScD, MPH, FISPE, vice president, global head epidemiology and scientific affairs

Saturday, August 26

4:15 p.m. – 5:45 p.m. ADT

Translating Real-World Evidence and Other Pharmacoepidemiological Research Findings Into Policy and Clinical Practice: How Well Are We Doing and What Are the Opportunities for Improvement?

Evidera Session Chair and Presenter: Meredith Y. Smith, PhD, MPA, FISPE

Poster Presentations

A Framework for Determining Sample Size for External Control Arms

Jack Ishak

Adapting clinical endpoints to a real-world setting in vaccine effectiveness and safety studies

Sarah Rosen, Paul Gillard, Delphine Saragoussi

Challenges and Mitigations of Conducting a Long-Term Effectiveness Study in a Rare Disease (Spinal Muscular Atrophy)

Linda Salem, Nahila Justo, Coralie Nguyen, Eleni Gaki Tammy McIver, Mai Duong, Noami Berfeld

Clinical validation studies for SARS-CoV-2 diagnostic tests in a real-world setting

Ronna L. Chan; Delphine Saragoussi; Tracy Horner; Susan Oliveria

Expanding Pregnancy Surveillance Programs to Assess Effects of Medicinal Product Exposure During Lactation

Kristin Veley, Kat Downes

Immunocompromised Conditions: Taxonomy, Epidemiology, and Health Care Data Coding – A Review and Initial Analysis of Several Ongoing Real-World Studies Using EHR in the US, UK, and Israel

Timothy Herring, Renata Yokota, Christen Gray, Sabada Dube, Carla Talarico, Idit Livnat, Sudhir Venkatesan, Aaron Kamauu, Scott DuVall, Toni Rush, Ghady Haidar, Nahila Justo, Yi Lu, Samah Hayek, Josef Levy, Dennis Cunningham, Vincent Willey, Michael Pollack

Lactation Studies of Biologics and Design Challenges

Kat Downes; Darin Brimhall; Susan McCune; Chimene Charbel; Kristin Veley

Lactation Studies: When are healthy volunteers an option?

Kat Downes; Darin Brimhall; Susan McCune; Chimene Charbel; Kristin Veley

Methodological approaches for external control arms in rare diseases

Ivana Sestak, Yuliya Halchenko, Mengyin Hong, Mireia Ralug, Debra Schaumberg, Delphine Saragoussi

Pediatric observational effectiveness evaluation studies in the EU PAS Register: What can we learn from study characteristics?

Sara Angleman; Sandra Okala; Alice Rouleau; Nahila Justo; Delphine Saragoussi